// App-Quantinova.ai

: Internal and External Validation of the High-2-Low Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant

Researchers

Presenter

  • Ang Li

Principal Investigators

  • Kylee L Martens

  • Daniel Nguyen

  • Gabriela Rondon

  • Christopher I Amos

  • Stephanie J. Lee

  • Ryan Basom

  • Chris Davis

  • David A. Garcia

  • Richard E. Champlin

  • Elizabeth J. Shpall

  • Cristhiam Mauricio Rojas Hernandez

  • Partow Kebriaei

Medical Centers

  • Division of Hematology, University of Washington, Seattle, WA

  • Hematology-Oncology, Baylor College of Medicine, Houston, TX

  • Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX

  • Department of Medicine, The University of Texas Health Science Center at Houston, Houston, TX

  • Division of Hematology and Medical Oncology, Oregon Health and Science University, PORTLAND, OR

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Pulmonary embolism

  • Solid malignancies

  • Graft-versus-host disease

Biomarkers

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved